April 27, 2026   Sweden
Direkt Studios: Market update and Q&A with CEO Anders Esssen- Möller
Diamyd Medical’s CEO Anders Essen-Möller, comments on the company’s updates. Viewers are welcome to submit questions via the chat.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS